Polly J Phillips-Mason
Overview
Explore the profile of Polly J Phillips-Mason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu B, Hale C, Persons L, Phillips-Mason P, de Boer P
J Bacteriol
. 2019 Jan;
201(8).
PMID: 30692172
Two key tasks of the bacterial septal-ring (SR) machinery during cell constriction are the generation of an inward-growing annulus of septal peptidoglycan (sPG) and the concomitant splitting of its outer...
2.
Phillips-Mason P, Craig S, Brady-Kalnay S
J Cell Biochem
. 2014 Apr;
115(9):1609-23.
PMID: 24771611
Cleavage of the cell-cell adhesion molecule, PTPµ, occurs in human glioblastoma multiforme brain tumor tissue and glioma cell lines. PTPµ cleavage is linked to increased cell motility and growth factor...
3.
Kaur H, Burden-Gulley S, Phillips-Mason P, Basilion J, Sloan A, Brady-Kalnay S
Neuro Oncol
. 2012 Apr;
14(5):561-73.
PMID: 22505657
Glioblastoma multiforme (GBM) is the most lethal primary brain tumor. Extensive proliferation and dispersal of GBM tumor cells within the brain limits patient survival to approximately 1 year. Hence, there...
4.
Kaur H, Phillips-Mason P, Burden-Gulley S, Kerstetter-Fogle A, Basilion J, Sloan A, et al.
Mol Cancer Res
. 2012 Jan;
10(3):293-304.
PMID: 22267545
Glioblastoma multiforme (GBM) is the most malignant and lethal form of astrocytoma. The GBM patient survival time of approximately 1 year necessitates the identification of novel molecular targets and more...
5.
Phillips-Mason P, Craig S, Brady-Kalnay S
Cell Adh Migr
. 2011 Jul;
5(4):298-305.
PMID: 21785275
Dissolution of cell-cell adhesive contacts and increased cell-extracellular matrix adhesion are hallmarks of the migratory and invasive phenotype of cancer cells. These changes are facilitated by growth factor binding to...
6.
Phillips-Mason P, Kaur H, Burden-Gulley S, Craig S, Brady-Kalnay S
J Cell Biochem
. 2010 May;
112(1):39-48.
PMID: 20506511
The receptor protein tyrosine phosphatase PTPµ has a cell-adhesion molecule-like extracellular segment and a catalytically active intracellular segment. This structure gives PTPµ the ability to transduce signals in response to...
7.
Burgoyne A, Phillips-Mason P, Burden-Gulley S, Robinson S, Sloan A, Miller R, et al.
Cancer Res
. 2009 Aug;
69(17):6960-8.
PMID: 19690139
Glioblastoma multiforme (GBM), the most common malignant primary brain tumor, represents a significant disease burden. GBM tumor cells disperse extensively throughout the brain parenchyma, and the need for tumor-specific drug...
8.
Burgoyne A, Palomo J, Phillips-Mason P, Burden-Gulley S, Major D, Zaremba A, et al.
Neuro Oncol
. 2009 Mar;
11(6):767-78.
PMID: 19304959
The cell-surface receptor protein tyrosine phosphatase mu (PTPmu) is a homophilic cell adhesion molecule expressed in CNS neurons and glia. Glioblastomas (GBMs) are the highest grade of primary brain tumors...
9.
Phillips-Mason P, Mourton T, Major D, Brady-Kalnay S
J Cell Biochem
. 2008 Sep;
105(4):1059-72.
PMID: 18773424
The receptor protein tyrosine phosphatase PTPmu belongs to a family of adhesion molecules that contain cell-cell adhesion motifs in their extracellular segments and catalytic domains within their intracellular segments. The...
10.
Phillips-Mason P, Gates T, Major D, Sacks D, Brady-Kalnay S
J Biol Chem
. 2005 Dec;
281(8):4903-10.
PMID: 16380380
The receptor protein-tyrosine phosphatase PTPmu is a member of the Ig superfamily of cell adhesion molecules. The extracellular domain of PTPmu contains motifs commonly found in cell adhesion molecules. The...